Skip to main content

Reporter March 5 2021

Markers for breast cancer progression

Mar. 9, 2021—Vanderbilt researchers clarify how a microRNA associated with triple-negative breast cancer survival inhibits cancer progression, suggesting new treatment strategies.

Read more


Temperature, newts and a skin-eating fungus

Mar. 8, 2021—Salamanders are more sensitive to a skin-eating fungus at colder temperatures, pointing to locations of North America where pathogen invasion is most likely.

Read more


VUMC mourns loss of radiology pioneer Payne

Mar. 5, 2021—W. Faxon Payne, MD, who helped establish the outpatient radiology service at The Vanderbilt Clinic beginning in 1987 until his appointment as emeritus professor in 1995 and retirement in 2000, died Feb. 16. He was 95.

Read more


Probiotic protection

Mar. 4, 2021—A probiotic factor given early in life to mice prevented intestinal inflammation in adulthood, providing a rationale for probiotic intervention in individuals at high risk of developing inflammatory bowel disease.

Read more


Monoclonal antibody “cocktail” blocks COVID-19 variants: study

Mar. 4, 2021—A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.

Read more


Targeting glucagon action in diabetes

Mar. 4, 2021—Disrupting the action of glucagon — a pancreatic hormone that works to raise blood glucose — restores functional insulin-producing cells in mouse models of type 1 diabetes and may be a promising treatment strategy.

Read more


Clinic helps prepare young HIV patients for adult care

Mar. 4, 2021—Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.

Read more


VHAN collaborations strengthened members during pandemic

Mar. 4, 2021—When the COVID-19 pandemic hit in 2020, members of the Vanderbilt Health Affiliated Network (VHAN) — a clinically integrated network in Tennessee and surrounding states that now includes more than 6,100 clinicians, 70 hospitals, 13 health systems and hundreds of physician practices and clinics — were hit with challenges they might have never previ

Read more


COVID-19 survey data added to All of Us platform

Mar. 4, 2021—In December 2020, the federal government’s massive precision medicine research initiative, All of Us (AoU), made available to qualified researchers initial results from its ongoing COVID-19 Participant Experience (COPE) Survey, as well as physical activity and heart rate data collected from Fitbit devices worn by AoU participants.

Read more


Biostatistician DeMets set for next Discovery Lecture

Mar. 4, 2021—David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture.

Read more


Chikungunya antibody identified at VUMC moves forward

Mar. 4, 2021—Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.

Read more


VUMC launches new medical equipment company Carefluent Connect

Mar. 3, 2021—After two years of planning and regulatory approvals, Vanderbilt University Medical Center is preparing to launch a durable medical equipment (DME) company, Carefluent Connect, LLC.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more